HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Vali, Bahareh ^a   Yue, Feng Yun ^a   Jones, R Brad ^a   Sheth, Prameet M ^a   Kaul, Rupert ^a   Betts, Michael R ^b   Wong, David ^c   Kovacs, Colin ^d   Loutfy, Mona ^d   Common, Andrew ^e   Halpenny, Roberta ^d   Ostrowski, Mario A ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d Canadian Immunodeficiency Research Collaborative   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; HEPATITIS B ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; LIVER PARENCHYMA; LYMPHOCYTE COUNT; MALE; MIXED INFECTION; T LYMPHOCYTE; BYSTANDER EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LIVER; LIVER DISEASE; VIROLOGY;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, VIRAL; BYSTANDER EFFECT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HEPATITIS C; HIV INFECTIONS; HIV-1; LIVER; LIVER DISEASES; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES;

EID: 55149099379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003454     Document Type: Article

References (30)

1. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, et al. (1996) Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 174: 690-695.
2. Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, et al. (2006) Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 3: e492.
3. Pol S, Lamorthe B, Thi NT, Thiers V, Carnol F, et al. (1998) Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 28: 945-950.
4. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, et al. (2001) Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33: 562-569.
5. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD (2000) Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. Jama 283: 74-80.
6. Kitamura K, Nakamoto Y, Akiyama M, Fujii C, Kondo T, et al. (2002) Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis. Lab Invest 82: 571-583.
7. Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, et al. (2001) The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 177: 112-120.
8. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458.
9. Valdez H, Carlson NL, Post AB, Asaad R, Heeger PS, et al. (2002) HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. Aids 16: 1113-1118.
10. Alatrakehi N, Graham CS, He Q, Sherman KE, Koziel MJ (2005) CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.J Infect Dis 191: 702-709.
11. Graham CS, Curry M, He Q, Afdhal N, Nunes D, et al. (2004) Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology 40: 125-132.
12. Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, et al. (2002) Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 76: 2817-2826.
13. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, et al. (2001) Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75: 11983-11991.
14. Sheth PM, Danesh A, Shahabi K, Rebbapragada A, Kovacs C, et al. (2005) HIV-sperific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J Immunol 175: 4789-4796.
15. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77: 11708-11717.
16. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-speciftc CD8+ T cells. Blood 107: 4781-4789.
17. Makedonas G, Betts M (2006) Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Sem Immunol 28: 209-219.
18. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP (2000) The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 174: 47-62.
19. Khatib R, Siddique M, Abbass M (1993) Measles associated hepatobiliary disease: an overview. Infection 21: 112-114.
20. Chan HL, Kwan AC, To KF, Lai ST, Chan PK, et al. (2005) Clinical significance of hepatic derangement in severe acute respiratory syndrome. World J Gastroenterol 11: 2148-2153.
21. Kahn JO, Walker BD (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339: 33-39.
22. Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, et al. (2006) Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 168: 1169-1178; quiz 1404-1165.
23. Banner BF, Allan C, Savas L, Baker S, Barnard G, et al. (1997) Inflammatory markers in chronic hepatitis C. Virchows Arch 431: 181-187.
24. Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, et al. (2005) Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42: 828-837.
25. Zhang L, Dailey PJ, Gettie A, Blanchard J, Ho DD (2002) The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys. J Virol 76: 5271-5273.
26. Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, et al. (1992) Identification and quantitation of HIV-1 in the liver of patients with AIDS. Aids 6: 65-70.
27. Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, et al. (2000) Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 165: 1082-1092.
28. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80: 11398-11403.
29. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
30. Dutoit V, Ciuffreda D, Comte D, Gonvers JJ, Pantaleo G (2005) Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol 35: 3493-3504.